Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30

$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica statistics

45 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: –

Share statisticsIndustry

Shares Outstanding: 980M; 58M
Shares Change (YoY): 0.00%; 10.8%
Shares Change (QoQ): 0.00%; 0.50%
Float: 953M; 49M
Shares Held by Insiders: 2.78%; 11.7%
Shares Held by Institutions: 0.01%; 56.4%

MarginsIndustry

Gross Margin: 64.0%; 53.1%
Operating Margin: -45.4%; -38.7%
Pretax Margin: -41.7%; -11.6%
Profit Margin: -41.4%; -31.6%
EBITDA Margin: -45.4%; -27.7%
FCF Margin: -30.8%; -9.56%

Returns on capitalIndustry

Return on Equity (ROE): -14.3%; -49.9%
Return on Assets (ROA): -13.0%; -40.6%
Return on Invested Capital (ROIC): -13.3%; -32.9%
Return on Capital Employed (ROCE): -16.6%; -37.9%

Financial positionIndustry

Current Ratio: 6.09; 3.30
Quick Ratio: 1.55; 2.39

GrowthIndustry

Revenue Growth (YoY): 31.3%; 6.82%
Revenue Growth (3Y CAGR): 19.2%; 2.25%

EfficiencyIndustry

Asset Turnover: 0.31; 0.40
Inventory Turnover: 2.47; 2.73
Revenue Per Employee: $274.33K; $429.29K
Profits Per Employee: -$113.44K; -$689.41K
Employee Count: 141; 74

Income statement (TTM)Industry

Revenue: $38.68M; $66.37M
Gross Profit: $24.74M; $120.78M
Operating Income: -$17.57M; -$21.37M
Pretax Income: -$16.14M; -$12.95M
Net Income: -$16.00M; -$22.35M
EBITDA: -$17.57M; -$17.21M
EPS (Diluted): $0.00; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $7.28M; $68.68M
Net Cash (Debt): $7.28M; $17.76M
Net Cash Per Share: $0.01; $0.80
Equity (Book Value): $104.28M; $53.89M
Book Value Per Share: $0.11; $1.50
Tangible Book Value: $67.63M; $27.13M
Working Capital: $46.34M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$11.48M; -$12.38M
Capital Expenditures: -$446.00K; -$1.00M
Free Cash Flow: -$11.92M; -$18.21M
FCF Per Share: -$0.01; -$0.42

Taxes and interestIndustry

Income Tax: -$140.00K; $73.00K

Scores and fair valueIndustry

Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

Period	ZOMDF	S&P 500	Difference	ZOMDF per year	S&P 500 per year
1 month	+2.1%	+0.6%	+1.5 pts
3 months	-8.2%	+3.4%	−11.5 pts
Year to date	-22.4%	+13.3%	−35.7 pts
1 year	+26.4%	+16.6%	+9.8 pts
3 years	-53.5%	+86.4%	−139.9 pts	-22.5%	+23.1%
5 years	-84.5%	+81.9%	−166.4 pts	-31.1%	+12.7%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ZOMDF shares were sold short on Oct 30, 2026, down 88.1% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	15,145	-88.1%	1,565,843	1.0
Oct 15, 2026	127,353	-11.8%	1,552,968	1.0
Sep 30, 2026	144,364	+14.3%	2,529,282	1.0
Sep 15, 2026	126,253	0.0%	1,059,414	1.0
Aug 31, 2026	126,253	-3.6%	1,121,907	1.0
Aug 14, 2026	130,987	-24.9%	1,311,974	1.0
Jul 31, 2026	174,392	+36.8%	1,094,198	1.0
Jul 15, 2026	127,453	-11.9%	1,192,481	1.0
Jun 30, 2026	144,634	+14.5%	2,937,425	1.0
Jun 15, 2026	126,263	-0.5%	2,481,161	1.0
May 29, 2026	126,857	-19.2%	1,640,522	1.0
May 15, 2026	156,949	+24.3%	1,963,273	1.0